There is another company whose SP quadrupled and now has sunk to less than the starting price - most would know who that company is. They look to have a good product given results from trials but they put out some very (over)optimistic media releases - and somewhat prematurely.
I would rather IMU do what they are doing and be a bit reserved about announcing anything until the ink has dried on phase 2 results. SP should rise significantly - but maybe more sustainably.
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-29
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.8¢ | 3.7¢ | $270.7K | 7.251M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 949810 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 2277658 | 11 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
